Cargando…
Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
PURPOSE: Circulating tumor DNA (ctDNA) has emerged as a promising tumor-specific biomarker in pancreatic cancer, but current evidence of the clinical potential of ctDNA is limited. In this study, we used comprehensive detection methodology to explore the utility of longitudinal ctDNA measurements in...
Autores principales: | Lapin, Morten, Edland, Karin H., Tjensvoll, Kjersti, Oltedal, Satu, Austdal, Marie, Garresori, Herish, Rozenholc, Yves, Gilje, Bjørnar, Nordgård, Oddmund |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068442/ https://www.ncbi.nlm.nih.gov/pubmed/36662807 http://dx.doi.org/10.1158/1078-0432.CCR-22-3526 |
Ejemplares similares
-
Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing
por: Tjensvoll, Kjersti, et al.
Publicado: (2022) -
Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging
por: Edland, Karin Hestnes, et al.
Publicado: (2023) -
Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study
por: Nordgård, Oddmund, et al.
Publicado: (2022) -
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
por: Lapin, Morten, et al.
Publicado: (2018) -
MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
por: Lapin, Morten, et al.
Publicado: (2016)